Sanford J Shattil

Title: Inventor Spotlight: Sanford J. Shattil

Introduction: Sanford J. Shattil is a notable inventor based in Narberth, Pennsylvania. With a keen focus on healthcare innovations, he holds a patent that addresses critical aspects of platelet interaction within the human body.

Latest Patents: His significant patent is titled "Inhibitors of Platelet Binding." This innovation features peptides that comprise the tripeptide sequence of arginine-tyrosine-aspartic acid, linked from amino- to carboxy-terminus. These peptides act as inhibitors of fibrinogen binding, platelet aggregation, glycoprotein IIb-IIIa binding, and related aberrant and normal physiological conditions.

Career Highlights: Throughout his career, Shattil has contributed to important advancements in biomedicine. He has worked with esteemed organizations such as the Trustees of the University of Pennsylvania and Merck & Co., Inc., where he utilized his expertise to drive forward research and development in medical applications.

Collaborations: During his professional journey, Shattil has collaborated with prominent colleagues, including Rebecca A. Taub and Paul A. Friedman. These partnerships have facilitated the exchange of ideas and the furtherance of innovations in the biomedical field.

Conclusion: Sanford J. Shattil's contributions to science through his patent have implications for understanding and potentially treating various platelet-related conditions. His work exemplifies the intersection of innovation and healthcare, showcasing the importance of inventors in advancing medical science.